How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91%

Ionis Pharmaceuticals (IONS) closed the last trading session at $38.26, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 59.65 indicates a 55.9% upside potential.The average comprises 20 short-term price targets ranging from a low of $37 to a high of$ 77, with a standard deviation of $10.76. While the lowest estimate indicates a decline of 3.3% from the current price l ...